List of Contents

U.S. Medical Billing Outsourcing Market Size, Share, and Trends 2024 to 2034

The U.S. medical billing outsourcing market size was USD 5.22 billion in 2023, estimated at USD 5.89 billion in 2024 and is anticipated to reach around USD 18.74 billion by 2034, expanding at a CAGR of 12.27% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 2413
  • Category : Healthcare

 

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Medical Billing Outsourcing Market 

5.1. COVID-19 Landscape: U.S. Medical Billing Outsourcing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact:  Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8.  U.S. Medical Billing Outsourcing Market, By Component

8.1. U.S. Medical Billing Outsourcing Market, by Component, 2024-2034

8.1.1 In-House

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Outsourced

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9.  U.S. Medical Billing Outsourcing Market, By Service

9.1. U.S. Medical Billing Outsourcing Market, by Service, 2024-2034

9.1.1. Front end

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Middle End

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Back End

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10.  U.S. Medical Billing Outsourcing Market, By End User 

10.1. U.S. Medical Billing Outsourcing Market, by End User, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Physician Offices

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. U.S. Medical Billing Outsourcing Market, Regional Estimates and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Component (2021-2034)

11.1.2. Market Revenue and Forecast, by Service (2021-2034)

11.1.3. Market Revenue and Forecast, by End User (2021-2034)

Chapter 12. Company Profiles

12.1. Allscripts Healthcare, LLC

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. R1RCM Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. eClinicalWorks

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cerner Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Kareo Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. McKesson Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Advanced MD, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Quest Diagnostics Incorporated

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Promantra Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Care Cloud

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

 

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client